Mereo BioPharma Group
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MREO and other ETFs, options, and stocks.About MREO
Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649).
CEODenise Vera Scots-Knight
CEODenise Vera Scots-Knight
Employees39
Employees39
HeadquartersLondon, Greater London
HeadquartersLondon, Greater London
Founded2015
Founded2015
Employees39
Employees39
MREO Key Statistics
Market cap38.15M
Market cap38.15M
Price-Earnings ratio-1.08
Price-Earnings ratio-1.08
Dividend yield—
Dividend yield—
Average volume1.88M
Average volume1.88M
High today$0.2587
High today$0.2587
Low today$0.2325
Low today$0.2325
Open price$0.253
Open price$0.253
Volume1.15M
Volume1.15M
52 Week high$3.05
52 Week high$3.05
52 Week low$0.20
52 Week low$0.20
MREO News
TipRanks 3d
Mereo BioPharma Shareholders Approve All AGM ResolutionsUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Analyst ratings
71%
of 7 ratingsBuy
71.4%
Hold
28.6%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.